The results showed that age, CVC, CRP, fibrinogen, D-dimer, vWF, FVIII, and treatment regimen immunomodulator (IMiD) were potential influencing factors for VTE in MM patients (see Table 1). Here, VWF is linked to Miyoshi myopathy.